What if you invested $1,000 in Gilead Sciences in 2020? (Inflation-Adjusted)
GILD · Healthcare · Adjusted to 2026 dollars using BLS CPI-U data
View nominal (non-adjusted) versionA $1,000 investment in Gilead Sciences in 2020 grew to $2,629 in nominal terms. But 2020 dollars had 25% more purchasing power than today. After adjusting for cumulative inflation using BLS CPI-U data, the real value of that growth works out to $2,103 in constant 2020 dollars, equivalent to a +12.1% real annualized return.
Nominal final value
$2,629
+162.9% total return
Real value (2020 dollars)
$2,103
+110.3% real total return
Real annualized return
+12.1%
vs. +16% nominal annualized
Year-by-Year (Inflation-Adjusted)
$1,000 in Gilead Sciences since 2020, values in constant 2020 dollars
| Year | Nominal Value | Real Value (2020 $) |
|---|---|---|
| 2020 | $1,000 | $1,000 |
| 2021 | $1,080 | $1,028 |
| 2022 | $1,179 | $1,028 |
| 2023 | $1,507 | $1,266 |
| 2024 | $1,459 | $1,191 |
| 2025 | $1,886 | $1,509 |
| 2026 | $2,832 | $2,266 |
Inflation adjustment uses BLS CPI-U annual data, deflated to 2026 dollars. Nominal stock data from Yahoo Finance (split-adjusted closing prices). Real values are expressed in constant 2020 purchasing-power dollars. For informational and educational purposes only. Not financial advice. Past performance does not guarantee future results. See our methodology and full disclaimer.